FITC Anti-Human CD16 Antibody[3G8]

FITC Anti-Human CD16 Antibody[3G8]

The FITC Anti-Human CD16 Antibody[3G8] is a monoclonal antibody that is designed to specifically target and bind to the CD16 antigen found on the surface of human natural killer cells and some subsets of T cells. This antibody is conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of the target cells using flow cytometry or fluorescence microscopy. The 3G8 clone of this antibody has been extensively characterized and validated for its specificity and sensitivity in detecting CD16-expressing cells.

This antibody is a valuable tool for researchers studying the role of natural killer cells and T cells in various physiological and pathological processes, such as immune surveillance, viral infections, cancer, and autoimmune diseases. By using this antibody, researchers can identify and quantify CD16-expressing cells in complex cell populations, such as peripheral blood mononuclear cells (PBMCs), tumor infiltrates, or lymphoid tissues. Moreover, this antibody can be used in combination with other antibodies targeting different cell surface markers to further characterize the phenotype and function of CD16-expressing cells.

The FITC Anti-Human CD16 Antibody[3G8] is available in different formats and sizes to suit different experimental needs. It can be purchased as a purified antibody for in vitro applications, such as flow cytometry, immunofluorescence, or western blotting. Alternatively, it can be conjugated with other fluorophores or enzymes for multiplexing or functional assays. This antibody is also suitable for in vivo studies, such as imaging or therapeutic applications, as it has been shown to have low immunogenicity and good pharmacokinetics. Overall, the FITC Anti-Human CD16 Antibody[3G8] is a reliable and versatile reagent for investigating the biology of CD16-expressing cells in health and disease.